These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 8834029

  • 1. Effect of octreotide on total effective vascular compliance in patients with posthepatitic cirrhosis.
    Lin HC, Tsai YT, Yang MC, Lee FY, Hou MC, Chen LS, Lee SD.
    J Hepatol; 1996 Jan; 24(1):81-7. PubMed ID: 8834029
    [Abstract] [Full Text] [Related]

  • 2. Effects of octreotide on postprandial systemic and hepatic hemodynamics in patients with postnecrotic cirrhosis.
    Lin HC, Tsai YT, Huang CC, Meng HC, Lee FY, Wang SS, Lee SD, Lo KJ.
    J Hepatol; 1994 Sep; 21(3):424-9. PubMed ID: 7836713
    [Abstract] [Full Text] [Related]

  • 3. Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis.
    Lin HC, Yang YY, Hou MC, Huang YT, Lee WC, Lee FY, Chang FY, Lee SD.
    Scand J Gastroenterol; 2002 Apr; 37(4):482-7. PubMed ID: 11989841
    [Abstract] [Full Text] [Related]

  • 4. Hemodynamic evaluation of octreotide in patients with hepatitis B-related cirrhosis.
    Lin HC, Tsai YT, Lee FY, Lee SD, Hsia HC, Lin WJ, Lo KJ.
    Gastroenterology; 1992 Jul; 103(1):229-34. PubMed ID: 1612330
    [Abstract] [Full Text] [Related]

  • 5. Effects of octreotide on central hemodynamics and systemic oxygen use in patients with viral cirrhosis.
    Lin HC, Hou MC, Lee WC, Huang YT, Lee FY, Chang FY, Tsai YT, Lee SD.
    Am J Gastroenterol; 1999 Apr; 94(4):1012-7. PubMed ID: 10201475
    [Abstract] [Full Text] [Related]

  • 6. Cardiovascular effects of octreotide in patients with hepatic cirrhosis.
    McCormick PA, Chin J, Greenslade L, Karatapanis S, Dick R, McIntyre N, Burroughs AK.
    Hepatology; 1995 May; 21(5):1255-60. PubMed ID: 7737631
    [Abstract] [Full Text] [Related]

  • 7. Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison.
    Baik SK, Jeong PH, Ji SW, Yoo BS, Kim HS, Lee DK, Kwon SO, Kim YJ, Park JW, Chang SJ, Lee SS.
    Am J Gastroenterol; 2005 Mar; 100(3):631-5. PubMed ID: 15743362
    [Abstract] [Full Text] [Related]

  • 8. Octreotide decreased liver metabolic activity in patients with hepatitis B surface antigen-positive cirrhosis.
    Lin HC, Tsai YT, Lee SD, Lee FY, Hsia HC, Meng HC, Wang SS, Lo KJ.
    Clin Pharmacol Ther; 1992 Aug; 52(2):134-8. PubMed ID: 1354573
    [Abstract] [Full Text] [Related]

  • 9. Total effective vascular compliance in patients with cirrhosis: a study of the response to acute blood volume expansion.
    Hadengue A, Moreau R, Gaudin C, Bacq Y, Champigneulle B, Lebrec D.
    Hepatology; 1992 May; 15(5):809-15. PubMed ID: 1568722
    [Abstract] [Full Text] [Related]

  • 10. Octreotide prevents postprandial splanchnic hyperemia in patients with portal hypertension.
    Albillos A, Rossi I, Iborra J, Lledó JL, Calleja JL, Barrios C, García P, Escartín P.
    J Hepatol; 1994 Jul; 21(1):88-94. PubMed ID: 7963427
    [Abstract] [Full Text] [Related]

  • 11. Total effective vascular compliance in patients with cirrhosis. Effects of propranolol.
    Andreu V, Perello A, Moitinho E, Escorsell A, García-Pagán JC, Bosch J, Rodés J.
    J Hepatol; 2002 Mar; 36(3):356-61. PubMed ID: 11867179
    [Abstract] [Full Text] [Related]

  • 12. Octreotide enhances portal pressure reduction induced by propranolol in cirrhosis: a randomized, controlled trial.
    Vorobioff JD, Ferretti SE, Zangroniz P, Gamen M, Picabea E, Bessone FO, Reggiardo V, Diez AR, Tanno M, Cuesta C, Tanno HE.
    Am J Gastroenterol; 2007 Oct; 102(10):2206-13. PubMed ID: 17608776
    [Abstract] [Full Text] [Related]

  • 13. Bolus somatostatin but not octreotide reduces hepatic sinusoidal pressure by a NO-independent mechanism in chronic liver disease.
    Matrella E, Valatas V, Notas G, Roumpaki H, Xidakis C, Hadzidakis A, Mouzas I, Kouroumalis E.
    Aliment Pharmacol Ther; 2001 Jun; 15(6):857-64. PubMed ID: 11380324
    [Abstract] [Full Text] [Related]

  • 14. Effect of octreotide on systemic, central, and splanchnic haemodynamics in cirrhosis.
    Møller S, Brinch K, Henriksen JH, Becker U.
    J Hepatol; 1997 May; 26(5):1026-33. PubMed ID: 9186833
    [Abstract] [Full Text] [Related]

  • 15. Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation.
    Cirera I, Feu F, Luca A, García-Pagán JC, Fernández M, Escorsell A, Bosch J, Rodés J.
    Hepatology; 1995 Jul; 22(1):106-11. PubMed ID: 7601400
    [Abstract] [Full Text] [Related]

  • 16. 48-hour hemodynamic effects of octreotide on postprandial splanchnic hyperemia in patients with liver cirrhosis and portal hypertension: double-blind, placebo-controlled study.
    Ludwig D, Schädel S, Brüning A, Schiefer B, Stange EF.
    Dig Dis Sci; 2000 May; 45(5):1019-27. PubMed ID: 10795771
    [Abstract] [Full Text] [Related]

  • 17. The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites.
    Kalambokis G, Economou M, Kosta P, Papadimitriou K, Tsianos EV.
    J Clin Gastroenterol; 2006 Apr; 40(4):342-6. PubMed ID: 16633107
    [Abstract] [Full Text] [Related]

  • 18. [The effects of octreotide on portal hemodynamics in patients with liver cirrhosis].
    Zhu Q, Jiang XH, Yi F, Jiang Y, Sun YW, Yuan YZ, Wu YL.
    Zhonghua Nei Ke Za Zhi; 2004 Jan; 43(1):16-8. PubMed ID: 14990014
    [Abstract] [Full Text] [Related]

  • 19. Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis.
    Kalambokis G, Economou M, Paraskevi K, Konstantinos P, Pappas C, Katsaraki A, Tsianos EV.
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1075-81. PubMed ID: 15955217
    [Abstract] [Full Text] [Related]

  • 20. [Effects of two different dosages of octreotide on portal pressure and hepatic hemodynamics in cirrhotic portal hypertensive patients after portal-azygous devascularization and splenectomy].
    Lu SC, Meng FK, Ding HG, Zhang JG, Ding L, Wang SZ.
    Zhonghua Nei Ke Za Zhi; 2007 Apr; 46(4):290-3. PubMed ID: 17637266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.